Ms Lynn Ann Richardson, RN, CNS in Brooklyn Center, MN - Medicare

Ms Lynn Ann Richardson, RN, CNS is a medicare enrolled "Clinical Nurse Specialist - Psychiatric/mental Health, Adult" in Brooklyn Center, Minnesota. Her current practice location is 5637 Brooklyn Blvd, Suite 200, Brooklyn Center, Minnesota. You can reach out to her office (for appointments etc.) via phone at (763) 971-2959.

Ms Lynn Ann Richardson is licensed to practice in Minnesota (license number R0661711) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1568563864.

Contact Information

	Ms Lynn Ann Richardson, RN, CNS
	5637 Brooklyn Blvd, Suite 200, Brooklyn Center, MN 55429-3081
	(763) 971-2959
	(763) 971-2959

Provider's Profile

Full Name	Ms Lynn Ann Richardson
Gender	Female
Speciality
Experience	Years
Location	5637 Brooklyn Blvd, Brooklyn Center, Minnesota
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Ms Lynn Ann Richardson attended and graduated from in

NPI Data:

NPI Number: 1568563864
Provider Enumeration Date: 09/26/2006
Last Update Date: 11/26/2008

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Ms Lynn Ann Richardson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568563864	NPI	-	NPPES
5379824	Other		CIGNA
6247871	Other		UNITED BEHAVIORAL HEALTH
448255700	Medicaid	MN
17F32RI	Other		BCBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SP0809X	Clinical Nurse Specialist - Psychiatric/mental Health, Adult	R0661711 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Lynn Ann Richardson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Lynn Ann Richardson, RN, CNS 5637 Brooklyn Blvd, Suite 200, Brooklyn Center, MN 55429-3081 Ph: (763) 971-2959	Ms Lynn Ann Richardson, RN, CNS 5637 Brooklyn Blvd, Suite 200, Brooklyn Center, MN 55429-3081 Ph: (763) 971-2959

News Archive

ImmunoGen presents IMGN529 data against NHL, CLL at AACR meeting

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

How household bleach kills bacteria

Despite the fact that household bleach is commonly used as a disinfectant, exactly how it works to fight bacteria remained an open question.

New book gives hope to women and families who are in difficult stages of anorexia treatment

Women and families struggling with an eating disorder or another addiction should never lose sight of the need to sustain the spirit, according to a new book by Jena Morrow, an author in recovery after more than 20 years with anorexia nervosa. Morrow, a behavioral health specialist at Timberline Knolls Residential Treatment Center, details a battle with anorexia that begins in early childhood in Hollow: An Unpolished Tale, recently released by Moody Publishers.

TetraLogic raises $32 million in Series C financing to advance clinical development of TL32711 cancer drug

TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody.

Ms Lynn Ann Richardson, RN, CNS - Medicare in Brooklyn Center, MN